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Stable CHO cell clones which selectively express all three rat tachykinin receptors were established by transfection. The binding of radiolabeled 
substance P and ncurokinin A (substance K) to CHO clones expressing the NK, and NK2 receptors, respectively. were snturatable and of high 
affinity (&=0.17 nM (NK,); 3.4 nM (NKJ). Scatchard analysis of the binding dam indicated for both receptors binding to a sin& population 
of binding sites, and competition binding studies howed that the binding specificities of the receptors corresponded towhose of classical NK, and 
NKz receptors. In contrast, the binding of cledoisin to the NK, receptor expressed in the transfectcd CHO cells was of low affinity (ICI,=240 nM) 
compared to the high affinity of the receptor found when it was transiently expressed in COS-7 cells (I&=8 nM). Howcvcr, in both cases the receptor 
exhibited the specificity of a classical NK, receptor. The established cell clones may provide an important ool for further analysis ofthe molecular 
mechanisms involved in binding. activation, and coupling of receptors for tachykinin peptides. 
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1. INTRODUCTION 
The mammalian tachykinins, substance P, neuroki- 
nin A (substance K) and ncurokinin B (neuromedin K) 
are characterized by the common carboxy-terminal sc- 
quence Phe-X-Gly-Leu-Met-NH?. They are widely dis- 
tributed neuropeptides in both the central and peri- 
pheral nervous ystem and involved in multiple biologi- 
cal actions including modulation of sensory afferent 
transmission, intestinal motility, stimulation of saliva- 
tion, vasodilation and activation of cells of the immune 
system (for reviews ee refs. [l-4]). 
The tachykinins act on at least three distinct receptors 
called NK,, NK? and NK3 which preferentially bind 
substance P, neurokinin A, and neurokinin J3, respec- 
tively [5-73. Recently Nakanishi and co-workers have 
isolated all three cDNA’s encoding these receptors by 
use of a Xcnopus expression system [8-lo]. The cloning 
of the NK, receptor was also recently reported by Her- 
shey and Krause 1990 [ll]. The predicted amino acid 
sequences of the receptors revealed homologous truc- 
tures typical for G protein coupled receptors character- 
ized by the presence of seven putative transmembrane 
domains [12]. Only a few neuropreptide r ceptors have 
been cloned until now and ihe tachykinin family was the 
first family of neuropeptides for which a series of differ- 
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ent receptor subtypes have bee2 cloned [12]. Hence, the 
tachykinin receptors constitute an optimal system for 
analyzing structure-function aspects of the binding and 
activation of receptors for neuropeptides. For example, 
it gives the opportunity to construct chimeric receptors 
between the receptor subtypes, an approach which has 
proven very useful1 with respect to the adrenergic recep- 
tors [ 133. 
In the present study we have established stable, trans- 
fected clones of CHO cells which selectively express the 
rat NK,, NK, and NK3 receptors. The binding proper- 
ties of the NKI and NK? receptors corresponded to 
those of the physiological, classical receptors. In con- 
trast, the NKJ receptors expressed inCHO cells were of 
low affmity as compared to NKJ receptors transiently 
expressed in COS-7 cells from the same plasmid. 
2. EXPERlMENTAL 
2, I , Pepr ides 
Substance P. neurokinin A. ncurokinin B and elcdoisin were pur- 
chased from Peninsula Laboratories. 
2.2. Esprcssio~t wlors, rrunsfecrion artd cell cuhrrc 
The cDNA encoding the NK,, NK: and NK, receptors were gcner- 
ously provided by Dr. S. Nakanishi, Kyoto University, Dcpl. of Me- 
dicine, Kyoto, Japan. The NK, receptor cDNA was excised from the 
original plasmid prTKR2 [9] as ti 2049 bp HindIII-EroRI fragment. 
the NKI receptor cDNA was excised from prTKRI-I [Id] as a 1,816 
bp EcoRI-BmtWl fragment and the NK, receptor cDNA was excised 
from prTKR3 [IO] as a 2.159 bp EcoRl-EcoKl fragment. These frag- 
mcnts were cloned into the pTEJ-8 exprczion vector under control of 
the ubiquitin promotor and the SW0 polyadenylation signal. The 
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expression vector also comains the nromycin phosphotranskrase g ne 
[15]. For stable expression fhe icsulting plasmids, pTE1&NKI, 
pTEJi3-NK2, and pTEJSmNK3 were iransfcclcd into CHOcclls hy the 
calcium phosphale precipilation method as described [l5,16]. For 
transient expression in COS-7 cells, IOh cells were seeded in a 90 mm 
culture plate and grown for 24 b before transfection by the calcium 
pbosphatc precipitalion method using 20 ,ug of DNA, After 24 h the 
cells were harvested, seeded in a 12~~ll culture plate and grown for 
another 24 h before analyzing. Cl-IO cells and COS-7 cells were grown 
as described [ 151. 
2.3. Prepararion atuf purificarion oJrudioligatxis 
Monoiodinated ‘251.Bolion Hunter subsi?ncc P (‘““I-BH-SP), ‘2sI- 
Bohon Hunter neurokinin A (‘zJI-BH-NKA) and 1~51-Bol~on Hunter 
eledoisin (lzSI-BH-ELE) were prepared according to earlier described 
mclbods [6]. The reaction mixlure was subjected to revcrscephasc 
HPLC as described [17]. The fractions containing the labeled pcptides 
were pooled and stored at -2OOC in acid ethanol containing 0.2% 
mercaptoclbanol. Under thcsc condhions the radioligands were stable 
for 2-3 month:,. As the separation of labeled and unlnbcled peptide 
was complete. :.he specific aclivity of ihe radioligands were assumed 
10 be equal to the specific activily of the Bollon Hunier rcagcnt (4.400 
cpm/fmol) after correctiorl for decay and counter eff&xcy. 
2.4. Bihcfing usqy 
Cells. Transfccted CHO-cells or CO!+7 cells were transferred 10 
either IZ-well culture plales (0.3-I ,0x IO’ccells) or 6-well culrurc plates 
(l&l .5 x IO0 cells) (Costar) 24 b before performing the binding assay. 
Culls were washed twice in phosphate-buffered saline, pH 7.4, (PBS) 
followed by incubation for 3 h at 4’C with 25-50 pM radioligand and 
varying concentrations of cold peplides in 0.5 ml or I .O ml of 150 mM 
N&I. 5 mM MnCI, in 50 mM HEPES, pH 7.4, supplemented with 
0.1% bovine serum albumin (Sigma), 100 pgpl bacitracin (Sigma), 5 
&+I leupeptin (Sims) and 10 p@l chymostatin (Sigma). 1.ne in- 
cubation media were rcmovcd and the cells were washed twice in 
ice-cold binding buffer. The cells were lysed in I ml lysis buffer (3 M 
acetic acid, 8 M urea and 24 Nonidet P-40) before counting. All 
daermina.tions were performed in rriplicalc. The unspecific binding 
was determined as the binding of radioligand in the presence of I PM 
cold peptide. The spcciflc binding constituted more than 90% of toial 
bound 011 the NK, receptor, more than 75% of total bound on the NK, 
receptor and more ihan 50% of total bound on the NK, receptor 
(CHO cells). In selected experiments the stability of the WBolton 
Hunler labeled peptides during incubations was checked by analyzing 
100 ,ul aliquols of the incubation media on an HPLC system as de- 
scribed above. Aher 3 h of incubation more than 85% of the mdioac- 
!ivity co-migraled with the radiolabeled peptides. 
Mctttbrcrnes. The cells wcrc harvcstcd in 5 mM ice-cold EDTA in 
PBS, pelleled by centrifugntion at 200 x g and homogenized using an 
Ullralurrax homogenizer in 25 mM Tris-HCI, pH 7.4, containing 100 
&&I bacitracin. 4 ,u&l leupeptin, IO pg&l chymostatin and 1 mM 
phenylmeihylsulfonyl fluorid (PMSFJ. The homogenate was cen- 
trifuged for I h at 25,000 x g and the pellct.ed membranes were re- 
suspended in the binding buffer. The membranes (2OOyg protein) were 
incubntcd for I.5 h ai 20°C with 50 pM ‘z51-BH-SP and various 
concentrations of cold pcptidc in 0.5 ml of a 25 mM HEPES buffer. 
pH 7.4, supplemented wilh 2 mM CaCI,, 1 mM M&la, 5 mM MnCI:, 
I% BSA and rhe above menlioncd proiease inhibitors. The incubation 
was stopped by the addition of 0.5 ml ice-cold binding buffer before 
centrifugation nt 3,500 xg for IO min. The pellet was washed in buffer, 
repelleled and counted. All binding data were analyzed by compu- 
terized non-linear regression analysis using GraphPAD, IS1 Software, 
Philadelphia, PA. 
2. i?ESixTS 
The stable NKl receptor transfectants bound 28-t-7% 
(mean f S.E.M., m=17; range 2.0-81%) of the added 
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Fig. I. Upper left pcltrel: specific binding of “‘I-BH-SP to CHO-NK I- 
5. The cells (CHO-NKI-5) were incubaled with 12’I-BH-SP (25 pM) 
and increasing concentralions of substance P as indicatr:d. Data arc 
i:xpressed as the specific binding in cpm (0) and are from a rcpresenta- 
tive experiment of three. The binding of ‘s51-BH.SP to CHO cells 
transrecied with the pTEZJ-8 expression vector alone is indicated (0). 
Scatchard analysis of the binding data are illuslrated in upper rig/u 
pmaf. toirrer fe_ff purzef: the spcciflc binding of ‘2’l-BH-NKA lo CHO. 
NK2-I. The cells (CHO-NK2-I), were incubated with “sl-BH-NKA 
(SO pM) and increasing concrntrations r neurokinin A as indicolcd. 
Data arc expressed as specific binding in cpm (0) and are from a 
representative xpcrimem of lhrec. The binding of lz51-BH-NKA to 
Cl-10 cells transfected with the pTEJ-8 expression vector alone is 
indicated (0). In lower rig/u pnnel Scatchard analysis of the binding 
data is shown. 
radio&and (‘“‘I-BH-SP), the NE& receptor transfectant 
bound 0.9&0.5% (mean t- S.E.M., n=6; range 0.05- 
2.2%) (‘“‘I-BH-NKA) and the NK3 receptor trans- 
fectants bound 1.31-0.18 (mean 2 S.E.M., ~25; range 
0.3-2.8%)(~~SI-BH-ELE) when assaying 1.0 x IO” cells 
in the presence of 50 pM radioligand. No specific bind- 
ing could be determined in either untransfected CHO 
cells or in CHO cells transfected with the expression 
vector alone. The NKI receptor clone with the highest 
level of radioligand binding (8 1 %), CHO-NK 1 - 11, and 
a clone with an intermediate l vel of radioligand bind- 
ing (24%), CHO-NKl-5, were selected for further char- 
acterization. To characterize the NI& receptor we 
chose the clone, CHO-NK2-1, which bound 2.1% of the 
radioligand and to characterize the NI& receptor we 
chose CHO-NK3-7 which bound 2.8% of the radio- 
ligand. 
The specific binding of ‘zsI-BH-SP to the NK, re- 
ceptor reached equilibrium after 2.5 h (not shown). The 
displacement of ‘251-13H-SP with increasing concentra- 
tions of ‘cold’ substance P showed that the specific bind- 
ing was of high affinity (Fig. 1, upper pacel). Scatchard 
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Fig. 2. Binding specificity of the NK, and NK2 receptor cxprcssed in 
CHO cells. Upper parwl: inhibition of ‘251-BH-SP binding to CHO- 
NK l-5 by substance P (0) (n= 12) (K, = ! .8 x IO-” M). ncurokinin A 
(A) (/l=(i) (& = 9.5 x IO-* M) and neurokinin B (m) (n=6) (Ki = 4.0 x 
IO-‘). Ltmw [~rrfrc(: inhibition of “‘1-BH-NKA binding to CHO-NK?- 
I by neurokinin A (A) (12~7) (& = 3.B x IO-y M), ncurokinin B (m) 
(rr=3) (Ki = I.3 x IO-’ M) and substance P (0) (11~3) (K; = 7.6 x IO-’ 
M). All the data are expressed as percent of maximum bound radio- 
liyand (mm&D.). 
analysis of the binding data showed that the CHO-NK I-5 
clone expressed a single high-affinity binding site with 
a & of 0.19-tO.03 nM and a S,,, corresponding to 
approx. 80,000 binding sites per cell (Fig. 1, upper panel 
and Table 1). The CHO-NKl-I 1 cell clone expressed, 
like CHO-NKl-5, a single high-affinity binding site as 
Table I 
Binding properties of the iat NK, and NK, rccepiors stably expressed 
in transfected CHO cells 
Cell clone &. -I,, n;e nm,l,brann. 
(nM) (nM) (fr%lO5 
Binding sites 
per cell 
cells) 
CHO-NKI-5 0.19 t 0.03 ND. 13.7 t 0.2 80,000 
CHO-NKI-I 1 0.14 ?: 0.01 0.2 4 0,l 52 zk3 300,000 
CHO-NK2-I 3.4 f 0.3 N.D. 3.6 f I.3 20,000 
The & and Em!,,, :‘nl~s arc cslcclated from Scatchard malysis of 
binding dota from ‘cold’ smration binding experiments a  described 
in Section 2. Data arc expressed as man I S.E.M. of three expcri- 
merits. N.D. = not determined. 
X of mar. 
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Fig. 3. Specific binding of ‘?‘I-BH-ELE LO the NK, receptor stably 
expressed in CHCJ cells (O-O) and transiently cxpresscd inCOS-7cells 
(c....Q The cells were incubated with SO pM ‘%DH-ELE and indi- 
cated concentrations of cledoisin. Data are cxprcsscd as percent of 
max. bound “‘I-BH-ELE (meant S.E.M., n=3). 
determined both on intact cells and cell membranes, 
Table I (not shown). 
The binding of “SI-BH-NKA to the NK2 receptor 
also reached equilibrium after 2.5 h (not shown). The 
binding was saturatable, of high affinity and to a single 
population of binding sites (approx. 20,000 per cell) 
(Fig. 1, lower panel and Table I). 
The specificity of the binding of ‘z51-13H-SP and tz51- 
BH-NKA to the NK, and NK, receptors expressed in 
CHO-cells was analyzed by competition binding stud- 
ies. As illustrated in Fig. 2, upper panel, substance P
most potently displaced “51-BH-SP from the NK, re- 
ceptor followed by neurokinin A and nerokinin B. On 
the NKz receptor, neurokinin A most potently displaced 
“‘I-BH-NKA followed by neurokinin B and substance 
P (Fig. 2, lower panel). 
In contrast to the results obtained on the NK, and 
NK2 receptors, we found that binding to the NK:, re- 
ceptor transfectants was apparently of low affinity (Fig. 
3). Thus, using “‘I-BH-ELE as radioligand I&, for 
eledoisin was 240 nMkl20 nM (mean P S.E.M., n=3). 
However, when the NK3 receptor was transiently ex- 
pressed in COS-7 cells, we obtained high-affinity bind- 
ing in the nanomolar ange (ICso = 8-t-2 nM, mean 1 
S.E.M., m=3) in accordance with previously published 
results [IO]. Transient expression of the NK, and NKI 
receptor in COS-7 cells also resulted in high-affinity 
binding (not shown). The specificity of the NKa re- 
ceptor transiently expressed in COS-7 cells correspon- 
ded likewise to previous results [IO] as the binding of 
‘z51-BH-ELE was inhibited most potently by neurokinin 
B (ICs, = 1.7 x lo-’ M) followed by eledoisin (I&, = 8 
x lo-” M), neurokinin A (ICI0 = 3.2 x IO-’ M) and 
substance P (ICsO = 1.8 x lo-’ M) (data not shown). A 
similar rank order of potency was obtained for the NK; 
receptor stably expressed in the CHO cells although the 
I&-, values were approx. 30-SO-fold higher. 
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4. DISCUSSION 
The construction of ceil lines which selectively ex- 
press a specific receptor subtype offers the advantage of 
a controlled system for structural and functional char- 
acterization of the receptors. Of the tachykinin recep- 
tors, the rat NK, and NK3 receptors have previously 
been transiently expressed inCOS-7 cells and the bovine 
NK2 receptor has recently been stably expressed in 
mouse B82 fibroblasts [l&19]. In the present study we 
have established stable CHO cell clones which selec- 
tively express all three rat tachykinin receptors. The 
NK, receptor and the NK, receptor demonstrated both 
high affinity and the expected specificity [4-73. In con- 
trast, the NK3 receptor exhibited low-affinity binding 
when expressed in CHO cells compared to the high 
affinity of the receptor when it was transiently expressed 
in COS-7 cells. The high affinity of the NK3 receptor 
when transiently expressed in COS-7 cells has also been 
demonstrated in previous studies [lo]. It is a generally 
accepted hypothesis that high-affinity binding of 
agonists to G protein-coupled receptors is dependent on 
the formation of a ternary complex between the agonist, 
the reqptor and at least the corresponding G protein 
a-subunit [20]. Thus, an explanation for the expression 
of low affinity NKS receptors in CHO cells would be 
that these cells do not express the correct G protein 
a-subunit, or at least not in a functional form. If the 
optimal a-subunit is absent or non-functional, rhe re- 
ceptor will interact with other a-subunits present, how- 
ever, with less efficiency [2 11. This could explain why we 
at all observe binding to the NK3 receptor expressed in 
the CM0 cells. In general, it is not expected to be pos- 
sible to detect binding of an agonist radioligand to a 
receptor which has been uncoupled from its corre- 
sponding G protein due to a too low agonist affinity 
POI. 
It is known that the CHO cells lack at least the GzO 
a-subunit (P.H. Andenen, personal communication) 
but it is unclear to which G protein cz-subunits he ta- 
chykinin receptors couple. The NK,, NK1, and NK, 
receptors are generally believed to couple to phospho- 
inosiride turnover via a pertussis toxin-insensitive mech- 
anism [3] a’nd it is likely that this involves ap a-subunit 
belonging to the so-called G,, class of a-subunits (for 
review see ref. [22]). However, the NKJ receptor has also 
been shown to inhibit CAMP accumulation through a 
pertussis toxin-sensitive mechanism which indicates 
that the NK, receptor may couple to an &subunit 
belonging to the Gi/G, class [233. Hence, the fact that 
the NKJ receptor is not expressed in its high-affmity 
form in CM0 cells may offer the opportunity to charac- 
terize the conversion of the receptor from its low-affin- 
ity for.m to its high-affinity f~rrn by e.g. comp!emcnta- 
tion through co-expression of different G protein a- 
subunits in these cells. 
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An alternative xplanation for the low affinity state 
of the NK3 receptor in CHO cells could possibly be 
found in the 71 amino acid-long, extracelhilar amino 
terminus of the NK3 receptor which contains four gly- 
cosylation sites compared to only two glycosylation 
sites in the 31-32 amino acid-long amino terminus of 
the NK, and NF_. receptors [9,10,14]. If CHO cells and 
COS-7 cells exhlblt different glycosylation patterns, the 
glycosylated amino terminus of the NKJ receptor could 
possibly interfere with ligand binding only in CHO cells. 
This should also be elucidated in the future by analyzing 
a NKJ receptor with a truncated amino terminus. 
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